CD8A and breast cancer: COX-2 overexpression impairs the function of cytotoxic CD8+ T lymphocytes, T helper (Th) lymphocytes, natural killer (NK) cells, and dendritic cells (DCs) [300], thereby diminishing the effectiveness of anti-breast cancer vaccines.